Telisotuzumab Vedotin

Telisotuzumab Vedotin C화학적 특성, 용도, 생산

개요

Telisotuzumab vedotin (Teliso-V) is an antibody drug conjugate that targets the MET receptor.

Clinical Use

In the first in-human phase I trial for Teliso-V, NSCLC patients with MET-overexpressing tumors received monotherapy. The results of this innovative trial indicated favorable safety and tolerability responses and also showed promising antitumor activity in NSCLC patients with MET overexpression.

Telisotuzumab Vedotin 준비 용품 및 원자재

원자재

준비 용품

Telisotuzumab Vedotin 공급 업체

공급자	전화	이메일	국가	제품 수	이점
TargetMol Chemicals Inc.		support@targetmol.com	United States	38463	58
DC Chemicals	021-58447131 13564518121	sales@dcchemicals.com	China	9410	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10362	58
bioleaper	18601717983	guojing@bioleaper.com	China	5616	58